top of page
< Back

Darunavir


Mechanism of action:

Darunavir is an HIV-1 protease inhibitor. Darunavir binds with high affinity to the active site of HIV-1 protease, preventing the enzyme from cleaving the Gag-Pol polyprotein precursor into functional proteins. As a result, newly produced viral particles remain immature and noninfectious.

Reference(s):

1. Back D et al. (2008). Darunavir: pharmacokinetics and drug interactions. Antivir Ther. 


2. Tremblay CL et al. (2008). Combating HIV resistance – focus on darunavir. Ther Clin Risk Manag. 


3. Koh Y et al. (2007). Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization. J Biol Chem.

bottom of page